Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Canopy Growth Corporation (CGC) vs Evotec AG (EVO)

Canopy Growth Corporation and Evotec AG are both Drug Manufacturers Specialty & Generic companies. Evotec AG is the larger, with a market value of $539.9M against $397.7M — 1.4× the size. Canopy Growth Corporation grew revenue faster over the last twelve months: 7.80% against 2.15%. Evotec AG has the higher net margin (−26.2% vs −80.4%) and the higher return on invested capital (0.00% vs −17.2%). Across the 18 metrics below, Evotec AG leads on 12 and Canopy Growth Corporation on 6.

Valuation

Metric CGC EVO Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.14
P/S 1.87 0.64 2.25
P/B 0.80 0.72 1.90
Price to free cash flow n/m n/m 16.54
EV/EBITDA n/m n/m 12.29
EV/Sales 1.52 0.65 2.56
Earnings yield (47.27%) (40.90%) (2.99%)
Free cash flow yield (15.29%) (36.14%) 0.00%

Profitability

Metric CGC EVO Drug Manufacturers Specialty & Generic median
Gross margin 25.16% 11.42% 53.94%
Operating margin (54.89%) (21.35%) 0.00%
Net margin (80.39%) (26.20%) 0.00%
Free cash flow margin (28.34%) 0.00% 0.00%
Return on equity (40.14%) 0.00% (0.40%)
Return on assets (23.54%) 0.00% (3.32%)
Return on invested capital (17.19%) 0.00% 0.00%

Growth

Metric CGC EVO Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 7.80% 2.15% 10.01%
EPS growth (last fiscal year) 84.00% 44.89% —
Revenue growth, 5-year CAGR (13.04%) 9.28% 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CGC EVO Drug Manufacturers Specialty & Generic median
Debt to equity 0.35 0.72 0.05
Current ratio 3.04 2.33 2.31
Net debt to EBITDA 1.09 (0.64) 0.85

Dividend

Metric CGC EVO Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.70%
Payout ratio 0.00 0.00 0.00

Size

Metric CGC EVO Drug Manufacturers Specialty & Generic median
Market cap 397.66m 539.87m 337.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack